Search

Frohling, S., C. Scholl, R. L. Levine, M. Loriaux, T. J. Boggon, O. A. Bernard, R. Berger, et al. 2007. “Identification of Driver and Passenger Mutations of FLT3 by High-Throughput DNA Sequence Analysis and Functional Assessment of Candidate Alleles”. Cancer Cell 12: 501-13.

Garraway, L. A., H. R. Widlund, M. A. Rubin, G. Getz, A. J. Berger, S. Ramaswamy, R. Beroukhim, et al. 2005. “Integrative Genomic Analyses Identify MITF As a Lineage Survival Oncogene Amplified in Malignant Melanoma”. Nature 436: 117-22.

Golub, T. R. 2001. “Genome-Wide Views of Cancer”. N Engl J Med 344: 601-2.

Golub, T. R. 2003. “Mining the Genome for Combination Therapies”. Nat Med 9: 510-1.

Golub, T. R. 2007. “Genomics: Global Views of Leukaemia”. Nature 446: 739-40.

Golub, T. R., G. F. Barker, K. Stegmaier, and D. G. Gilliland. 1996. “Involvement of the TEL Gene in Hematologic Malignancy by Diverse Molecular Genetic Mechanisms”. Curr Top Microbiol Immunol 211: 279-88.

Halmos, B., D. S. Basseres, S. Monti, F. D’Alo, T. Dayaram, K. Ferenczi, B. J. Wouters, C. S. Huettner, T. R. Golub, and D. G. Tenen. 2004. “A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3 Beta As a Novel Tumor Suppressor in Lung Cancer”. Cancer Res 64: 4137-47.

Hoshida, Y., and T. R. Golub. 2009. “Prolonged Therapy for Hepatitis C With Low-Dose Peginterferon”. N Engl J Med 360: 1152; author reply 1152-3.

Stathias, V., A. M. Jermakowicz, M. E. Maloof, M. Forlin, W. Walters, R. K. Suter, M. A. Durante, et al. 2018. “Drug and Disease Signature Integration Identifies Synergistic Combinations in Glioblastoma”. Nat Commun 9: 5315.

Stegmaier, K., S. Takeuchi, T. R. Golub, S. K. Bohlander, C. R. Bartram, and H. P. Koeffler. 1996. “Mutational Analysis of the Candidate Tumor Suppressor Genes TEL and KIP1 in Childhood Acute Lymphoblastic Leukemia”. Cancer Res 56: 1413-7.